Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells
Back to article page
Original Article|Updated:2023-12-20
|
Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells
Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells
中国结合医学杂志(英文版)2024年30卷第1期 页码:25-33
Affiliations:
1.School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou (311121), China
2.Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines;Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou (311121), China
3.Department of Colorectal Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
4.Beijing Tong Ren Tang Chinese Medicine Co., Ltd., Beijing(100000), China
5.Department of Traditional Chinese Medicine, Hangzhou Shangcheng District People's Hospital, Hangzhou(310006), China
6.Department of Gynecology, Hangzhou Women's Hospital, Hangzhou (310008), China
Author bio:
Dr. JIN Li-jun, E-mail: 58646061@qq.com;
Dr. SHANG Rui-yan, E-mail: ruiyanshanghzfcyy@163.com
Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells[J]. 中国结合医学杂志(英文版), 2024,30(1):25-33.
GAO Quan, LI Lin, ZHANG Qi-man, et al. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells[J]. Chinese Journal of Integrative Medicine, 2024,30(1):25-33.
Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells[J]. 中国结合医学杂志(英文版), 2024,30(1):25-33. DOI: 10.1007/s11655-023-3710-4.
GAO Quan, LI Lin, ZHANG Qi-man, et al. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells[J]. Chinese Journal of Integrative Medicine, 2024,30(1):25-33. DOI: 10.1007/s11655-023-3710-4.
Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells
摘要
Abstract
Objective:
2
To determine whether monotropein has an anticancer effect and explore its potential mechanisms against colorectal cancer (CRC) through network pharmacology and molecular docking combined with experimental verification.
Methods:
2
Network pharmacology and molecular docking were used to predict potential targets of monotropein against CRC. Cell counting kit assay
plate monoclonal assay and microscopic observation were used to investigate the antiproliferative effects of monotropein on CRC cells HCT116
HT29 and LoVo. Flow cytometry and scratch assay were used to analyze apoptosis and cell cycle
as well as cell migration
respectively in HCT116
HT29
and LoVo cells. Western blotting was used to detect the expression of proteins related to apoptosis
cell cycle
and cell migration
and the expression of proteins key to the Akt pathway.
Results:
2
The Gene Ontology and Reactome enrichment analyses indicated that the anticancer potential of monotropein against CRC might be involved in multiple cancer-related signaling pathways. Among these pathways
RAC-beta serine/threonine-protein kinase (Akt1
Akt2)
cyclin-dependent kinase 6 (CDK6)
matrix metalloproteinase-9 (MMP9)
epidermal growth factor receptor (EGFR)
cell division control protein 42 homolog (CDC42) were shown as the potential anticancer targets of monotropein against CRC. Molecular docking suggested that monotropein may interact with the 6 targets (Akt1
Akt2
CDK6
MMP9
EGFR
CDC42). Subsequently
cell activity of HCT116
HT29 and LoVo cell lines were significantly suppressed by monotropein (
P
<
0.05). Furthermore
our research revealed that monotropein induced cell apoptosis by inhibiting Bcl-2 and increasing Bax
induced G 1 –S cycle arrest in colorectal cancer by decreasing the expressions of CyclinD1
CDK4 and CDK6
inhibited cell migration by suppressing the expressions of CDC42 and MMP9 (
P
<
0.05)
and might play an anticancer role through Akt signaling pathway.
Conclusions:
2
Monotropein exerts its antitumor effects primarily by arresting the cell cycle
causing cell apoptosis
and inhibiting cell migration. This indicates a high potential for developing novel medication for treating CRC.
关键词
Keywords
monotropeinChinese medicineanticancer activitycolorectal cancer cellsnetwork pharmacology
Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation
Chinese Medicine as Supporting Therapy for Psoriasis:Past, Present, and Future
Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer
Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin Ⅱ Formula (冠心Ⅱ号方) for Coronary Heart Disease
相关作者
暂无数据
相关机构
The Second Clinical Medical College, Guangzhou University of Chinese Medicine
Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine
Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology
Key Laboratory of Cosmetics Monitoring and Evaluation, State Drug Administration, Shenzhen Institute for Drug Control
The School of Basic Medical Sciences, Hubei University of Chinese Medicine